JWEL Q2 2025 Earnings Report

Page 1

NEWS RELEASE Jamieson Wellness Inc. Reports Second Quarter 2025 Results 2025-08-07 Jamieson Brands revenue up 13.8% Highly successful 6/18 program in China grows 73% over prior year TORONTO--(BUSINESS WIRE)-- Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its second quarter results for the period ended June 30, 2025. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other nancial measures. See “Non-IFRS and Other Financial Measures” below. Management Commentary “Q2 marked another solid quarter, reinforcing the continued strength of the health and wellness category and Jamieson’s leadership within it," said Mike Pilato, President and CEO of Jamieson Wellness. "Branded revenue growth of nearly 14 percent reects both sustained global demand for our trusted brands and our team's precise execution of our strategic plan across all key markets. “In Canada, our 'Proudly Canadian' platform continues to resonate with consumers driving strong consumption growth while our innovation pipeline drives category-leading performance. In the U.S., youtheory is gaining traction through our traditional retail presence and our new ecommerce partnership, with strong consumption growth validating our strategy. In China, our successful 6/18 campaign delivered exceptional growth as our investment in brand awareness continues to resonate with consumers. And internationally, we're seeing continued momentum driven by innovation, particularly across the Middle East and Southeast Asia. 1

Page 2

“In the rst half of 2025, our branded business expanded by nearly 14%, with growth across all our branded business units. As we head into the second half of the year we’re pleased to increase our quarterly dividend, as we have done every year as a public company. We remain focused on executing our innovation roadmap, expanding our global reach, and driving operational excellence. Built on our 103-year foundation of quality and trust, we're executing from an even stronger position as we continue to Inspire Better Lives Every Day." Second Quarter Highlights New Jamieson innovation, notably behind the trending magnesium category and “Proudly Canadian” marketing programs drove strong consumer consumption in Canada Highly successful 6/18 promotion in China achieved 73% growth over prior year Trending ingredients drove increased youtheory consumption including accelerated growth in stress support and a market-leading product in the energy category New product launches and successful heart and women’s health campaigns drove sell through in many International markets Summary of Consolidated Results All comparisons are with the second quarter of 2024 Consolidated revenue increased 7.7% to $199.1 million, driven by 13.8% growth in Jamieson Brands partially oset by an expected decline in Strategic Partners Gross prot increased by $15.8 million to $80.8 million; normalized gross prot increased by $14.2 million largely driven by higher branded revenue and margins Gross prot margin 3 increased by 540 basis points; normalized gross prot margin increased 460 basis points due to favourable channel mix and prior year ineciencies EBITDA 1 increased by $5.8 million to $30.1 million, mainly driven by higher revenues and gross prot; Adjusted EBITDA 1 increased by $3.5 million or 11.2% to $35.1 million, reecting the impact of higher sales volumes, partially oset by timing of investments in SG&A Net earnings was $13.8 million; Adjusted net earnings 1 was $17.3 million, or $2.6 million higher, reecting higher normalized earnings from operations Diluted earnings per share was $0.30; Adjusted diluted earnings per share 2 was $0.40 Summary of Segment Results All comparisons are with the second quarter of 2024 2

Page 3

Jamieson Brands Revenue increased 13.8% or $21.5 million Canada revenue increased by 2.0%, driven by strong consumer consumption, partially oset by the impact of order fulllment in Q2 prior year after the labour disruption in the rst quarter China revenue increased 70.8% driven by a successful 6/18 promotional campaign, continued brand loyalty growth behind our brand building investment, and a heavier weighting of inuencer programs scheduled in the quarter youtheory revenue increased by 9.7% mainly driven by strong consumption in e-commerce driven by our new strategic partnership, growth in our traditional channels, and timing of shipments of our Q3 promotional programs International revenue increased by 9.6% driven by growth in core markets in the Middle East and Asia Gross prot increased by $17.0 million to $78.3 million; normalized gross prot increased by $15.4 million mainly driven by revenue growth and higher margins Gross prot margin 3 increased by 480 basis points; normalized gross prot margin increased by 370 basis points mainly driven by volume eciencies compared to ineciencies due to the labour disruption in the prior year and favourable channel mix Adjusted EBITDA 1 increased by $4.8 million to $33.5 million, driven by higher gross prot partially oset by timing of SG&A to support growth and brand awareness in China; Adjusted EBITDA margin 2 was 18.9%, an increase of 50 basis points mainly due to improved gross prot margins Strategic Partners Revenue decreased an expected 24.9% or $7.2 million, impacted by the timing of customer ordering patterns under new programs and shipments shifting to the second half of the year Gross prot decreased by $1.2 million; gross prot margin 3 decreased by 110 basis points driven mainly by production mix Adjusted EBITDA 1 was $1.6 million, a decrease of $1.2 million; Adjusted EBITDA margin 2 was 7.5%, a decrease of 240 basis points Balance Sheet and Cash Flow from Operations All comparisons are with the second quarter of 2024 As at June 30, 2025, the Company had approximately $132.9 million in cash and available revolving and swingline facilities and net debt 1 of $367.1 million The Company generated $11.4 million in cash from operations compared to $6.9 million generated in Q2 3

Page 4

2024 Cash from operating activities before working capital considerations of $18.8 million was $1.7 million higher than Q2 2024 Cash invested in working capital decreased by $2.9 million mainly due to timing of vendor payments, partially oset by the timing of customer collections and increased inventories to support the growth of the business During the six-month period ended June 30, 2025, the Company purchased for cancellation 444,580 Common Shares under its normal course issuer bid (“NCIB”) program for an aggregate consideration of $13.1 million 1 This is a non-IFRS nancial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on eachnon-IFRS nancial measure.2 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.3 This is a supplementary nancial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information oneach supplementary nancial measure. Adjusting Fiscal 2025 Outlook The Company is maintaining its consolidated revenue and Adjusted EBITDA outlook for the 2025 scal year and continues to anticipate the following: Revenue to range between $800.0 to $840.0 million (9.0% to 14.5% growth) Adjusted EBITDA to range from $157.0 to $163.0 million (11.0% to 15.5% growth) The Company is adjusting its outlook for the 2025 scal year to reect higher Jamieson Brands revenue in China due to strong demand, and lower Strategic Partners revenue to account for the timing of onboarding new partners. As such, the Company now expects the following: Revenue in the Jamieson Brands segment to range between $695.0 to $725.0 (10.5% to 15.3% growth), updated from the Company’s previous expectation of $685.0 to $720.0 million (9.0% to 14.5% growth) Jamieson China revenue to grow 30.0% to 40.0%, updated from the previous range of 25.0% to 35.0%. Growth will be driven by market growth, innovation, and by further extending eectiveness and eciency within digital programs driving trial and awareness. Revenue in the Strategic Partners segment to range between $105.0 to $116.0 (up to 10.0% growth), updated from the Company’s previous expectation of $116.0 to $121.0 million (10.0% to 15.0% growth) Growth is expected to be driven by new programs and industry growth propelling higher volumes within the Company’s existing program portfolio. Uncertainties surrounding U.S. taris have delayed launches of new programs and the timing of onboarding new customers have shifted revenues to the following year. 4

Page 5

In addition, Adjusted diluted earnings per share is expected to range from $1.79 to $1.90 (11.0% to 18.0% growth), reecting higher interest expense on the repurchase of shares under the NCIB program and timing of seasonal working capital investments. The Company’s 2025 guidance reects the current prevailing trade environment between the United States, Canada and other countries. To date, taris have not had a material impact on the Company’s overall nancial performance, as these costs have been mitigated through the Company’s exible supply chain and operating eciencies. The Company recognizes that the trade environment is constantly changing and actual results may be impacted by future changes in global trade policies. For additional details on the Company’s scal 2025 outlook, including guidance for the third quarter of 2025, refer to the “Outlook” section in the management’s discussion and analysis of nancial condition and results of operations (“MD&A”) for the three and six months ended June 30, 2025. Declaration of Second Quarter Dividend The board of directors of the Company authorized a 2.0 cent or a 9.5% increase in the quarterly dividend and declared a cash dividend for the second quarter of 2025 of $0.23 per common share, or approximately $9.5 million in total. Payable: September 12, 2025 Record date: August 29, 2025 Designated an “eligible dividend” under the Income Tax Act (Canada) Consolidated Financial Statements and Management’s Discussion and Analysis The Company’s unaudited condensed consolidated interim nancial statements and accompanying notes as at and for the three and six months ended June 30, 2025 and related MD&A are available under the Company’s prole on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com. Conference Call Management will host a conference call to discuss the Company’s second quarter 2025 results at 5:00 p.m. ET today, August 7, 2025. To access: By phone: 1-800-717-1738 from Canada and the U.S. or 1-646-307-1865 from international locations Online: https://investors.jamiesonwellness.com or https://viavid.webcasts.com/starthere.jsp? ei=1726891&tp_key=eee3aa172e 5

Page 6

About Jamieson Wellness Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada's #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also oers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information please visit jamiesonwellness.com. Jamieson Wellness’ head oce is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada. Forward-Looking Information This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to the Company’s anticipated results and its outlook for its 2024 revenue, Adjusted EBITDA and Adjusted diluted earnings per share. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. This information reects the Company’s current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to dier materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2025 and under the “Risk Factors” section in the MD&A led today, August 7, 2025. This information is based on the Company’s reasonable assumptions and beliefs in light of the information currently available to it and the statements are made as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law or regulatory authority. The Company cautions that the list of risk factors and uncertainties is not exhaustive and other factors could also adversely aect the Company’s results. Readers are urged to consider the risks, uncertainties and assumptions associated with these statements carefully in evaluating the forward-looking information and are cautioned not to place undue reliance on such information. See “Forward-looking Information” and “Risk Factors” within the MD&A for a discussion of the uncertainties, risks and assumptions associated with these statements. 6

Page 7

Jamieson Wellness Inc. Selected Consolidated Financial InformationIn thousands of Canadian dollars, except share and per share amounts Three months endedSix months endedJune 30 June 30 2025 2024 2025 2024 Revenue 199,109184,806345,072312,844 Cost of sales 118,295119,778209,038205,031 Gross prot 80,814 65,028 136,034107,813 Gross prot margin 40.6% 35.2% 39.4% 34.5% Selling, general and administrative expenses55,346 43,867 104,933 83,425 Share-based compensation 2,078 1,744 4,165 3,493 Earnings from operations23,39019,41726,93620,895Operating margin 11.7% 10.5% 7.8% 6.7% Foreign exchange gain (1,749) (180) (1,245) (951)Interest expense and other nancing costs4,771 4,647 9,679 9,520 Accretion on preferred shares1,155 2,121 3,427 4,340 Earnings before income taxes19,213 12,829 15,075 7,986 Provision for income taxes 5,385 4,516 3,761 3,392 Net earnings 13,8288,31311,3144,594Net earnings attributable to: Shareholders 13,071 8,653 10,625 4,540 Non-controlling interests 757 (340) 689 54 13,8288,31311,3144,594Adjusted net earnings17,26714,65423,21518,569 EBITDA 30,11824,35837,91531,507 Adjusted EBITDA 35,10031,55554,16647,652 Adjusted EBITDA margin17.6% 17.1% 15.7% 15.2%Weighted average number of shares Basic 41,712,20741,456,59441,845,27841,468,227Diluted 43,065,91642,472,62343,104,10142,304,411 Earnings per share attributable to commonshareholders: Basic, earnings per share 0.31 0.20 0.25 0.11Diluted, earnings per share 0.30 0.20 0.25 0.11Adjusted diluted, earnings per share0.40 0.35 0.54 0.44 Jamieson Wellness Inc. Consolidated Statements of Financial PositionIn thousands of Canadian dollars June 30, 2025December 31, 2024AssetsCurrent assets Cash 50,537 44,787Accounts receivable 165,085 228,031Inventories 191,939 154,658Derivatives 1,238 2,661Prepaid expenses and other current assets6,167 6,803 Income taxes recoverable 5,272 - 420,238436,940Non-current assets Property, plant and equipment 101,302 103,591Goodwill 279,433 287,503Intangible assets 364,747 377,214 Deferred income tax 4,265 3,545 Total assets 1,169,9851,208,793 LiabilitiesCurrent liabilities Accounts payable and accrued liabilities 139,102 137,653Income taxes payable 1,345 4,373Di i 4767 2982 7

Page 8

Derivatives 4,767 2,982 Current portion of other long-term liabilities17,790 27,673 163,004172,681Long-term liabilities Long-term debt 417,652 308,285Post-retirement benets 1,268 1,209Deferred income tax 63,594 64,467Redeemable preferred shares - 98,138 Other long-term liabilities 13,409 15,633 Total liabilities 658,927660,413Equity Share capital 328,879 326,219Warrants 14,705 14,705Contributed surplus 25,014 23,835Retained earnings 82,436 99,109 Accumulated other comprehensive income17,336 41,313 Total shareholders' equity 468,370505,181 Non-controlling interests 42,688 43,199 Total equity 511,058548,380 Total liabilities and equity 1,169,9851,208,793 Non-IFRS and Other Financial Measures This press release makes reference to certain nancial measures, including non-IFRS nancial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary nancial measures. Management uses these nancial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the protability of ongoing operations and in analyzing the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s nancial information reported under IFRS. The Company uses the following non-IFRS nancial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable nancial measure for each that is disclosed in its nancial statements being net earnings, “normalized gross prot”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable nancial measures for each that is disclosed in its nancial statements being gross prot, SG&A, earnings from operations, cash ows from operating activities, and long-term debt, respectively, the following non- IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross prot margin”, “normalized operating margin”, and the following supplementary nancial measures: “gross prot margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS nancial measures. Management also uses non-IFRS and supplementary nancial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How 8

Page 9

we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS nancial measure to its most directly comparable nancial measure disclosed in the Company’s nancial statements to which the measure relates. The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross prot to normalized gross prot, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS nancial measures (see the “Non- IFRS and Other Financial Measures” of this press release for further information on each non-IFRS nancial measure) for the three and six months ended June 30, 2025. Jamieson Wellness Inc. Segment InformationIn thousands of Canadian dollars, except as otherwise noted Jamieson Brands Three months ended June 30 2025 2024$ Change% Change Revenue 177,317155,787 21,530 13.8%Gross prot 78,251 61,284 16,967 27.7%Labour relations costs(1) - 1,414 (1,414) (100.0%) Acquisition and divestiture related costs (2) - 165 (165) (100.0%) Normalized gross prot 78,251 62,863 15,388 24.5%Gross prot margin 44.1% 39.3% - 4.8%Normalized gross prot margin44.1% 40.4% - 3.7%Share-based compensation (3) 2,078 1,744 334 19.2%Selling, general and administrative expenses53,767 42,262 11,505 27.2%Acquisition and divestiture related costs (2) - (324) 324 100.0%IT system implementation (4) (3,796) (3,449) (347) (10.1%)Legal and other(6) (857) - (857) (100.0%) Labour relations costs(1) - (281) 281 100.0% Normalized selling, general and administrative expenses49,114 38,208 10,906 28.5% Earnings from operations22,40617,2785,128 29.7% Acquisition and divestiture related costs (2) - 489 (489) (100.0%)IT system implementation (4) 3,796 3,449 347 10.1%Labour relations costs(1) - 1,695 (1,695) (100.0%) Legal and other (6) 857 - 857 100.0% Normalized earnings from operations27,05922,9114,148 18.1%Operating margin 12.6% 11.1% - 1.5%Normalized operating margin15.3% 14.7% - 0.6%Adjusted EBITDA 33,45528,6914,764 16.6%Adjusted EBITDA margin18.9% 18.4% - 0.5%Strategic Partners Three months ended June 30 2025 2024$ Change% Change Revenue 21,792 29,019 (7,227) (24.9%)Gross prot 2,563 3,744 (1,181) (31.5%)Gross prot margin 11.8% 12.9% - (1.1%)Selling, general and administrative expenses1,579 1,605 (26) (1.6%) Earnings from operations984 2,139 (1,155) (54.0%)Operating margin 4.5% 7.4% - (2.9%)Adjusted EBITDA 1,645 2,864 (1,219) (42.6%)Adjusted EBITDA margin7.5% 9.9% - (2.4%)Jamieson Brands Six months ended June 30 2025 2024$ Change% Change 9

Page 10

Revenue 308,698271,135 37,563 13.9%Gross prot 132,041102,414 29,627 28.9%Labour relations costs(1) - 4,667 (4,667) (100.0%)IT system implementation (4) 1,023 - 1,023 100.0% Acquisition and divestiture related costs (2) - 165 (165) (100.0%) Normalized gross prot 133,064107,246 25,818 24.1%Gross prot margin 42.8% 37.8% - 5.0%Normalized gross prot margin43.1% 39.6% - 3.5%Share-based compensation(3) 4,165 3,493 672 19.2%Selling, general and administrative expenses101,807 80,323 21,484 26.7%Acquisition and divestiture related costs (2) - (324) 324 100.0%IT system implementation (4) (8,082) (6,429) (1,653) (25.7%)Labour relations costs(1) - (1,721) 1,721 100.0%Donations(5) (3,118) - (3,118) (100.0%) Legal and other (6) (882) (297) (585) (197.0%) Normalized selling, general and administrative expenses89,725 71,552 18,173 25.4% Earnings from operations26,06918,5987,471 40.2% Acquisition and divestiture related costs (2) - 489 (489) (100.0%)IT system implementation (4) 9,105 6,429 2,676 41.6%Labour relations costs(1) - 6,388 (6,388) (100.0%)Donations(5) 3,118 - 3,118 100.0% Legal and other (6) 882 297 585 197.0% Normalized earnings from operations39,17432,2016,973 21.7%Operating margin 8.4% 6.9% - 1.5%Normalized operating margin12.7% 11.9% - 0.8%Adjusted EBITDA 51,72843,8157,913 18.1%Adjusted EBITDA margin16.8% 16.2% - 0.6%Strategic Partners Six months ended June 30 2025 2024$ Change% Change Revenue 36,374 41,709 (5,335) (12.8%)Gross prot 3,993 5,399 (1,406) (26.0%) IT system implementation (4) 226 - 226 100.0% Normalized gross prot 4,219 5,399 (1,180) (21.9%)Gross prot margin 11.0% 12.9% - (1.9%)Normalized gross prot margin11.6% 12.9% - (1.3%)Selling, general and administrative expenses3,126 3,102 24 0.8% Earnings from operations867 2,297 (1,430) (62.3%) IT system implementation (4) 226 - 226 100.0% Normalized earnings from operations1,093 2,297 (1,204) (52.4%)Operating margin 2.4% 5.5% - (3.1%)Normalized operating margin3.0% 5.5% - (2.5%)Adjusted EBITDA 2,438 3,837 (1,399) (36.5%)Adjusted EBITDA margin6.7% 9.2% - (2.5%) Reconciliation of Non-IFRS Financial Measures In thousands of Canadian dollars Three months endedSix months endedJune 30 June 30 2025 2024 2025 2024 Net earnings: 13,8288,31311,3144,594 Add:Recovery of income taxes 5,385 4,516 3,761 3,392Interest expense and other nancing costs4,771 4,647 9,679 9,520Accretion on preferred shares1,155 2,121 3,427 4,340Depreciation of property, plant, and equipment3,474 3,236 6,729 6,752 Amortization of intangible assets1,505 1,525 3,005 2,909 Earnings before interest, taxes, depreciation, andamortization (EBITDA)30,11824,35837,91531,507 Share-based compensation (3) 2,078 1,744 4,165 3,493Foreign exchange gain (1,749) (180) (1,245) (951)Labour relations costs(1) - 1,695 - 6,388IT system implementation (4) 3,796 3,449 9,331 6,429Acquisition and divestiture related costs (2) - 489 - -Donations(5) - - 3,118 - Legal and other(6) 857 - 882 297 10

Page 11

Adjusted EBITDA 35,10031,55554,16647,652 Recovery of income taxes (5,385) (4,516) (3,761) (3,392)Interest expense and other nancing costs(4,771) (4,647) (9,679) (9,520)Depreciation of property, plant, and equipment(3,474) (3,236) (6,729) (6,752)Amortization of intangible assets(1,505) (1,525) (3,005) (2,909)Share-based compensation (3) (1,956) (1,622) (3,921) (3,249)Tax deduction from vesting of certain share-based awards(19) - (708) - Tax eect of normalization adjustments(723) (1,355) (3,148) (3,261) Adjusted net earnings17,26714,65423,21518,569 Three months endedSix months endedJune 30 June 30 2025 2024 2025 2024 Gross prot 80,81465,028136,034107,813 Labour relations costs(1) - 1,414 - 4,667Acquisition and divestiture related costs (2) - 165 - 165 IT system implementation (4) - - 1,249 165 Normalized gross prot80,81466,607137,283112,645 Normalized gross prot margin40.6% 36.0% 39.8% 36.0%Selling, general and administrative expenses55,34643,867104,93383,425 Acquisition and divestiture related costs (2) - (324) - (324)IT system implementation (4) (3,796) (3,449) (8,082) (6,429)Labour relations costs(1) - (281) - (1,721)Donations(5) - - (3,118) - Legal and other (6) (857) - (882) (297) Normalized selling, general and administrativeexpenses 50,69339,81392,85174,654 Earnings from operations23,39019,41726,93620,895 Acquisition and divestiture related costs (2) - 489 - 489IT system implementation (4) 3,796 3,449 9,331 6,429Donations(5) - - 3,118 -Labour relations costs(1) - 1,695 - 6,388 Legal and other(6) 857 - 882 297 Normalized earnings from operations28,04325,05040,26734,498 Normalized operating margin14.1% 13.6% 11.7% 11.0% (1)These expenses are mainly comprised of third-party legal, security fees, unavoidable facility expenditures, customer nes and penalties, along withfreight charges to expedite shipments to customers as it relates to a labour disruption in Q1 2024.(2)Prior year expenses mainly pertain to legal, consulting and integration costs associated with the acquisition and integration of our formerdistributor partner in China on April 28, 2023.(3)The Company’s share-based compensation expense pertains to our long-term incentive plan (the “LTIP”) (refer to “Share-based compensation”), withstock options, performance-based share units (“PSUs”), time-based restricted share units (“RSUs”), and deferred share units (“DSUs”) expenses,along with associated payroll taxes.(4)Mainly pertains to development costs associated with our IT system implementation to augment our system infrastructure. Unlike other systemimprovement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.(5)Include cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildres.(6)Includes other non-recurring expenses primarily related to non-operational legal costs. Reconciliation of Net Debt In thousands of Canadian dollars ($ in 000's) As at June 30,As at December 31,2025 2024 Long-term debt 417,652308,285 Cash (50,537) (44,787) Net debt 367,115263,498 Investor and Media Contact Information: Jamieson Wellness 11

Page 12

Ruth Winker 416-960-0052 rwinker@jamiesonlabs.com Source: Jamieson Wellness Inc. 12

Earnings release